Linking Baseline PSMA PET–Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [ <sup>177</sup> Lu]Lu-PSMA-617: A Single-Center Retrospective Study
Year: 2025
Type: article
Language: en
Topic: Prostate Cancer Treatment and Research
Authors and affiliations:
raw_author_name: Vishnu Murthy
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Koichiro Kimura
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; koichirokimura@mednet.ucla.edu
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Lela Theus
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Andrew Nguyen
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Tristan R. Grogan
raw_affiliation_strings: Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Ojaswita Lokre
raw_affiliation_strings: AIQ Solutions, Madison, Wisconsin
raw_author_name: Timothy Perk
raw_affiliation_strings: AIQ Solutions, Madison, Wisconsin
raw_author_name: Matthew B. Rettig
raw_affiliation_strings: Department of Medicine, VA Greater Los Angeles, Los Angeles, California; and
Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
Department of Medicine, VA Greater Los Angeles, Los Angeles, California
raw_author_name: Alexandra Drakaki
raw_affiliation_strings: Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: John Shen
raw_affiliation_strings: Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Pan Thin
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Kathleen Nguyen
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Stephanie Lira
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Rejah Marie Nabong
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Linda Gardner
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Brian D. Gonzalez
raw_affiliation_strings: Moffitt Cancer Center, Tampa, Florida
raw_author_name: Andrei Gafita
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Johannes Czernin
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
raw_author_name: Jeremie Calais
raw_affiliation_strings: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California